Covered recipient · General Payments record
ELIZABETH A LARSEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,485.34
- Reported across 148 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $575.31 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $329.72 | 18 |
| Organon LLC | $64.49 | 4 |
| Novo Nordisk AS | $28.98 | 2 |
| IRONSHORE PHARMACEUTICALS INC. | $23.50 | 1 |
| Janssen Pharmaceuticals, Inc | $20.94 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $18.87 | 1 |
| Lilly USA, LLC | $16.52 | 1 |
| Biogen, Inc. | $15.61 | 1 |
| GlaxoSmithKline, LLC. | $15.58 | 1 |
| Axsome Therapeutics, Inc. | $14.91 | 1 |
| Acerta Pharma LLC | $13.10 | 1 |
| Exeltis, USA Inc. | $13.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.18 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510639 | CMS |
| ABBVIE INC. | $13.48 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510641 | CMS |
| ABBVIE INC. | $13.19 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510643 | CMS |
| ABBVIE INC. | $31.38 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510645 | CMS |
| ABBVIE INC. | $4.21 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510647 | CMS |
| ABBVIE INC. | $22.19 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510649 | CMS |
| ABBVIE INC. | $27.42 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510651 | CMS |
| ABBVIE INC. | $14.95 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510653 | CMS |
| ABBVIE INC. | $31.32 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510655 | CMS |
| ABBVIE INC. | $5.33 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510657 | CMS |
| ABBVIE INC. | $4.01 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510659 | CMS |
| ABBVIE INC. | $18.52 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510661 | CMS |
| ABBVIE INC. | $34.75 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510663 | CMS |
| ABBVIE INC. | $24.05 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510665 | CMS |
| ABBVIE INC. | $27.81 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510667 | CMS |
| ABBVIE INC. | $3.61 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510669 | CMS |
| ABBVIE INC. | $5.42 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510671 | CMS |
| ABBVIE INC. | $20.90 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510673 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.10 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104373005 | CMS |
| Axsome Therapeutics, Inc. | $14.91 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148356602 | CMS |
| Biogen, Inc. | $15.61 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104823766 | CMS |
| Boston Scientific Corporation | $18.87 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092664603 | CMS |
| Exeltis, USA Inc. | $13.09 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150015089 | CMS |
| GlaxoSmithKline, LLC. | $15.58 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115883689 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $23.50 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146269494 | CMS |
| Janssen Pharmaceuticals, Inc | $20.94 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078220521 | CMS |
| Lilly USA, LLC | $16.52 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135617955 | CMS |
| Novo Nordisk Inc | $14.28 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100293298 | CMS |
| Novo Nordisk Inc | $14.70 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100640224 | CMS |
| Organon Llc | $21.74 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136252309 | CMS |
| Organon Llc | $14.06 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136252317 | CMS |
| Organon Llc | $10.25 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136252321 | CMS |
| Organon Llc | $18.44 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136252325 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.